author-photo

Helmut Oettle

Charité
Humboldt University of Berlin

182

Papers

8878

Citations

Citation Trend

Filter By

Papers (182) Sort By

JournalConferenceOthers

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (6)
TP53 mutations predict sensitivity to adjuvant gemcitabine in patients with pancreatic ductal adenocarcinoma: next-generation sequencing results from the CONKO-001 trial.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (12)
190P Outcomes from the Asian region of the phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for patients (pts) with resected pancreatic cancer (PC)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial

2019 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (10)
PANTHEON-Studie: Versorgungsforschungsstudie zur Untersuchung des Überlebens von Patienten mit metastasiertem Bauchspeicheldrüsenkrebs nach sequenzieller Chemotherapie: Eine Phase-II-Studie der AIO mit Cross-over-Design

2019 The Forum
- Helmut Oettle
Show All
- Source
- Cite
- Save
Citations (0)
Reliability of determining the resectability of locally progressed pancreatic ductal adenocarcinomas - results from the first 200 patients of the CONKO-007 multicenter randomized controlled trial (EudraCT:2009-014476-21)

2018 Pancreatology
Show All
- Source
- Cite
- Save
Citations (0)
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

2018 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (99)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号